BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21555238)

  • 1. Serum fatty acid synthase concentration is increased in patients with hepatitis viral infection and may assist in the prediction of liver steatosis.
    Joven J; Espinel E; Rull A; Beltrán-Debón R; Aragonès G; Rodríguez-Gallego E; Camps J; Pedro-Botet J; Sans T; Menéndez JA; Alonso-Villaverde C
    J Clin Virol; 2011 Jul; 51(3):199-201. PubMed ID: 21555238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
    Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
    Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
    Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology.
    Vere CC; Neagoe D; Streba CT; Prejbeanu I; Ianoşi G; Comănescu V; Pirici D
    Rom J Morphol Embryol; 2010; 51(3):509-14. PubMed ID: 20809028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
    Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis in Iranian patients with chronic hepatitis C.
    Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
    Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of serum leptin levels in chronic hepatitis C with steatosis.
    Ellidokuz E; Cömlekçi A; Ellidokuz H; Akpinar H; Gökçe C; Tankurt E; Sagol O; Simsek I; Gönen O
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxix-cclxxii. PubMed ID: 15244198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
    Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.